Meyer Vitabiotics, a leading pharmaceutical manufacturer, has conducted a study revealing the potential of an antioxidant blend, Oligocare Forte Plus, to significantly improve male fertility. The study, involving 300 Indian males with varying types and degrees of infertility, aimed to evaluate the safety, efficacy, and tolerability of the supplement containing multi-vitamins, minerals, essential amino acids, ginseng, and lycopene.
Results demonstrated a 75.76% increase in sperm count among participants with a baseline sperm count of less than 5 million/ml. The trial focused on the efficacy of antioxidant therapy for male infertility, specifically improving semen parameters and the DNA Fragmentation Index (DFI). The Oligocare Forte Plus tablet, known as Wellman Conception in the UK, combines essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health.
Meyer Vitabiotics’ groundbreaking study offers hope for a more accessible, cost-effective, and clinically efficient approach to addressing male infertility through antioxidant and micronutrient therapy. The results highlight the potential of multi-micronutrient therapy as a promising alternative to traditional treatment options.
